Share on LinkedInShare on LinkedIn

ARTICLE · 28 OCTOBER 2024

Calendarization Process For The Market Authorization Of Medicines

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

The Guidelines for the Calendarization Process of Medicinal Products for Human Use (the "Guidelines") aims to regulate the process for the market authorization applications...

TurkeyIntellectual Property

Introduction

The Guidelines for the Calendarization Process of Medicinal Products for Human Use (the "Guidelines") aims to regulate the process for the market authorization applications on medicinal products for human use filed with the Turkish Medicines and Medical Devices Agency (the "Agency"). The Agency has determined the procedures and principles for calendarization processes of the applications found eligible in the pre-assessments. The Guidelines has been initially published on the official website of the Agency in 2023 and has been updated in December 2023, February 2024 and August 2024.

Calendarization Processes

Pursuant to the Guidelines, the calendarization information of the market authorization applications found eligible in the pre-assessments, is announced with two separate lists published in the official website of the Agency in the first week of every month: "List of Active Ingredients Pending Calendarization" and "Active Ingredient List of

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from